FDA’s priority review gives opioid-overdose reversal drug expected approval date of March 2023, company says

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Family warned authorities of suspected gunman in North Carolina standoff, sheriff says

Just days before a man in North Carolina died by apparent suicide…

Want a shot? Vaccination sites offer volunteers a chance to jump the line

When Pat Cook signed up to volunteer at a vaccination site in…

NYC jail captain said inmate was ‘faking it’ as he killed himself, prosecutors say

A New York City corrections captain was charged with negligent homicide on…

Republicans warned this day would come. Then they forgot.

WASHINGTON — Rick Perry tried to warn voters of the dangers of…